Myriad Genetics buy melinda
Start price
10.09.17
/
50%
€32.62
Target price
22.01.18
€42.00
Performance (%)
18.73%
End price
22.01.18
€38.73
Summary
This prediction ended on 22.01.18 with a price of €38.73. The prediction had a final performance of 18.73%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Myriad Genetics | -3.556% | -3.556% | -52.826% | -77.908% |
| iShares Core DAX® | -2.526% | -5.194% | 4.911% | 51.996% |
| iShares Nasdaq 100 | -0.032% | 1.561% | 21.789% | 95.664% |
| iShares Nikkei 225® | -4.202% | -7.550% | 31.128% | 52.994% |
| iShares S&P 500 | -0.802% | 0.160% | 15.782% | 66.529% |
Comments by melinda for this prediction
In the thread Myriad Genetics diskutieren
$
Myriad Genetics, Inc.
GeneSight® Gezeigte Deutlich zu generalisierten Angststörung Ansprechen auf die Behandlung verbessern Statistisch gesehen und verringern Benzodiazepinkonsum
(Vom Mitglied beendet)